TRCT
INLX icon

Tower Research Capital (TRC)’s Intellinetics INLX Stock Holding History

Tower Research Capital (TRC)’s Portfolio INLX Stock Details INLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Buy
903
+490
+119% +$3.28K ﹤0.01% 4325
2026
Q1 		$3.08K Buy
413
+314
+317% +$2.45K ﹤0.01% 4368
2025
Q4 		$790 Sell
99
-56
-36% -$518 ﹤0.01% 4819
2025
Q3 		$1.79K Buy
+155
New +$1.81K ﹤0.01% 4730
2025
Q2 		– Sell
-416
Closed -$5.16K – 5413
2025
Q1 		$5.16K Buy
416
+141
+51% +$1.76K ﹤0.01% 4151
2024
Q4 		$3.78K Sell
275
-69
-20% -$952 ﹤0.01% 4592
2024
Q3 		$3.85K Sell
344
-953
-73% -$8.4K ﹤0.01% 4755
2024
Q2 		$8.3K Sell
1,297
-337
-21% -$2.36K ﹤0.01% 4369
2024
Q1 		$14.4K Buy
1,634
+74
+5% +$527 ﹤0.01% 3311
2023
Q4 		$7.89K Sell
1,560
-565
-27% -$2.5K ﹤0.01% 4565
2023
Q3 		$9.63K Buy
2,125
+923
+77% +$3.63K ﹤0.01% 4199
2023
Q2 		$4.35K Buy
1,202
+1,188
+8,486% +$4.61K ﹤0.01% 4957
2023
Q1 		$0 Sell
14
-313
-96% -$1.33K ﹤0.01% 6051
2022
Q4 		$1K Buy
+327
New +$1.33K ﹤0.01% 5606

Other funds holding INLX

BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s INLX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Intellinetics (INLX) stake by 119% in Q2 2026, buying an estimated $3.28K and bringing the position to 903 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4325.

Tower Research Capital (TRC) first reported a position in INLX in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.4K in Q1 2024. 9 funds tracked by Wall St. Rank hold INLX as of Q2 2026.

  • Tower Research Capital (TRC) held 903 shares of Intellinetics worth $4.97K as of Q2 2026.
  • Tower Research Capital (TRC) bought 490 Intellinetics shares in Q2 2026, an estimated $3.28K.
  • Intellinetics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4325 holding.
  • Tower Research Capital (TRC) first reported a position in Intellinetics in Q4 2022 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Intellinetics position peaked at $14.4K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Intellinetics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.